Evaluation of blood glucose, hepatic biomarkers and histopathology of alloxan induced diabetic rats fed Sesamum indicum compounded diet
1 Department of Biochemistry, School of Biological Sciences, Federal University of Technology, Owerri Imo State, Nigeria.
2 Department of Biochemistry, Faculty of Basic Medicine, University of Uyo Akwaibom State, Nigeria.
Research Article
World Journal of Advanced Research and Reviews, 2023, 19(02), 751–761
Article DOI: 10.30574/wjarr.2023.19.2.1657
Publication history:
Received on 07 July 2023; revised on 14 August 2023; accepted on 16 August 2023
Abstract:
This study was aimed at evaluating the blood glucose level, hepatic biomarkers and histology of alloxan induced diabetic rats fed with Sesamum indicum compounded diet. Thirty-Six male albino rats were divided into nine groups (normal control, diabetic control, standard drug-glibenclamide treated, diabetic rats fed with 15%, 30% and 60% Sesamum indicum compounded diet and normal rats fed with 15%, 30% and 60% Sesamum indicum compounded diet and induced with diabetics after 14 days) of four rats each and the study lasted for 21 days. The induction of diabetes was done by a single dose of freshly prepared alloxan (120 mg/kg b.wt.) given intraperitoneally. The level of blood glucose was determined using Acu-check glucometer while the hepatic biomarkers was determined using standard spectrophotometric method. The blood glucose of the groups fed with the diet were observed to reduce when compared with the diabetic untreated group. Significant (p<0.05) reduction was observed for the hepatic biomarkers when compared with diabetic control. From the histopathology of the liver, the results showed improved liver for the groups fed with the compounded diet when compared with the diabetic control group that showed a damaged liver. The results of this study have shown that Sesamum indicum has both protective and ameliorative effect on blood glucose, hepatic biomarkers and restore the distorted liver of a diabetic rat.
Keywords:
Sesamum indicum; Alloxan; Diabetes; Glibenclamide; Protective; Ameliorative
Full text article in PDF:
Copyright information:
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0